| For: | Li XY, Guan QX, Shang YZ, Wang YH, Lv SW, Yang ZX, Wang R, Feng YF, Li WN, Li YJ. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. World J Gastroenterol 2021; 27(26): 4208-4220 [PMID: 34326620 DOI: 10.3748/wjg.v27.i26.4208] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i26/4208.htm |
| Number | Citing Articles |
| 1 |
Wei Cao, Zezhi Lin, Daoyi Zheng, Jianjun Zhang, Weili Heng, Yuanfeng Wei, Yuan Gao, Shuai Qian. Metal–organic gels: recent advances in their classification, characterization, and application in the pharmaceutical field. Journal of Materials Chemistry B 2023; 11(44) doi: 10.1039/D3TB01612A
|
| 2 |
Rohit Sharma, Thakur Gurjeet Singh, Keshav Raj Paudel, Kamal Dua, Avneet Kour, Dinesh Kumar Chellappan, Poonam Negi. Bioorganic design of metal–organic frameworks for targeted and stimuli-responsive anticancer drug delivery. Journal of Materials Science 2026; doi: 10.1007/s10853-026-12660-9
|
| 3 |
QingXia Guan, XiaoYing Zhou, FangFang Yang, Xue Zhang, YanHong Wang, WeiNan Li, XiuYan Li. A novel strategy against hepatitis B virus: Glycyrrhetnic acid conjugated multi-component synergistic nano-drug delivery system for targeted therapy. Journal of Biomaterials Applications 2023; 37(8) doi: 10.1177/08853282221139132
|
| 4 |
Jiang Yayun, Ge Qianqian, Sun Xihang, Hong Yang, Hou Zhenping, Li Yuying, Ma Xiancheng, Jiang Qian, Shi Pengjun. Metal-organic framework-mediated antioxidant enzyme delivery in disease treatment. Redox Biology 2025; 85 doi: 10.1016/j.redox.2025.103778
|
| 5 |
Bing-Tao Zhai, Jing Sun, Ya-Jun Shi, Xiao-Fei Zhang, Jun-Bo Zou, Jiang-Xue Cheng, Yu Fan, Dong-Yan Guo, Huan Tian. Review targeted drug delivery systems for norcantharidin in cancer therapy. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01703-3
|
| 6 |
Wang Sun, Xianhui Zhao, Erin Webb, Gang Xu, Weijie Zhang, Yang Wang. Advances in metal–organic framework-based hydrogel materials: preparation, properties and applications. Journal of Materials Chemistry A 2023; 11(5) doi: 10.1039/D2TA08841J
|
| 7 |
Zahra Chavoshpour-Natanzi, Akbar Omidvar, Nahid Farzi. Reactive insights: DFT and QTAIM analysis of interactions between amino acids constituting Cytochrome C and the metal–organic framework IR-MOF-74-VI. Molecular Simulation 2026; doi: 10.1080/08927022.2026.2681686
|
| 8 |
Zi-Jun Yan, Xiao-Ping Wu, Pan-Pan Wei, Meng-Yue Deng, Kun Yang, Liang-Ming Zhang, Yu-Zhen Ding, Die Xia, Bing-Suo Ma, Lei Zhang, Xiao-Yan Yuan, Tong Chen. Effective Platform for Enhancing the Bioavailability and Anti-Cancer Efficacy of Norcantharidin: Nanoemulsion Hybrid Lipid Carriers. Journal of Biomedical Nanotechnology 2023; 19(4) doi: 10.1166/jbn.2023.3574
|
| 9 |
Xiaoying Xu, Yu Liu, Yanyan Liu, Yahan Yu, Mingqi Yang, Ligong Lu, Leung Chan, Bing Liu. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02547-9
|
| 10 |
Katarina Sokač Pogrmilović, Gordana Matijašić, Krunoslav Žižek. Modulation of Drug Release in Anticancer Therapy: Recent Advances, Challenges, and Emerging Drug Delivery Platforms. Pharmaceutics 2026; 18(6) doi: 10.3390/pharmaceutics18060698
|
| 11 |
Susu Xiao, Yu Wang, Wenqiong Ma, Ping Zhou, Biqiong Wang, Zhouxue Wu, Qian Wen, Kang Xiong, Yanlin Liu, Shaozhi Fu. Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma. Drug Delivery 2022; 29(1) doi: 10.1080/10717544.2022.2111480
|
| 12 |
Zhi-Yu Xia, Hao-Liang Peng, Yong You, Lu Zhang, Qiu-Ying Deng, Lei Zhou, Si-Lin Chen, Xin-Yi Guo, Jing-Xing Guo, Dong-Bing Cheng. Research progress of norcantharidin nanodrugs for tumor treatment. Nanoscale 2025; 17(30) doi: 10.1039/D5NR01530H
|
| 13 |
Dongge Yin, Xueling Hu, Mengru Cai, Kaixin Wang, Hulinyue Peng, Jie Bai, Yvchen Xv, Tingting Fu, Xiaoxv Dong, Jian Ni, Xingbin Yin. Preparation, Characterization, and In Vitro Release of Curcumin-Loaded IRMOF-10 Nanoparticles and Investigation of Their Pro-Apoptotic Effects on Human Hepatoma HepG2 Cells. Molecules 2022; 27(12) doi: 10.3390/molecules27123940
|
| 14 |
Jie Zhang, Tongtong Tian, Canyu Li, Yong Liu, Yunyun Wang, Ling Liu, Liang Liu, Yufeng Yao. Cantharidin: a double-edged sword in medicine and toxicology. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1644186
|
| 15 |
Haoyue Ning, Lixin Lu. Isoreticular Metal-Organic Framework-3 (IRMOF-3): From Experimental Preparation, Functionalized Modification to Practical Applications. Polymers 2024; 16(15) doi: 10.3390/polym16152134
|
| 16 |
Zijun Yan, Kun Yang, Xiang Tang, Yunfeng Bi, Yuzhen Ding, Mengyue Deng, Die Xia, Yunqi Zhao, Tong Chen, Fu Wang. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Journal of Immunology Research 2022; 2022 doi: 10.1155/2022/3851604
|
| 17 |
Miaodong Wang, Peichun Peng, Zeshan Chen, Xin Deng. Nanoparticle Delivery of Active Traditional Chinese Medicine Ingredients:
A New Strategy for the Treatment of Liver Cancer. Current Pharmaceutical Biotechnology 2023; 24(13) doi: 10.2174/1389201024666230313151316
|
| 18 |
Yilin Xu, Min Wang, Jing Wu, Manshu Zou, Donghai Wu, Jing Gong, Pingjie Wang, Hong Yan, Xinhua Xia. Targeted treatment of hepatocellular carcinoma with aptamer-guided solid lipid nanoparticles loaded with norcantharidin. Drug Delivery 2025; 32(1) doi: 10.1080/10717544.2025.2519470
|
| 19 |
Shuang Wu, Wei Zhang. Norcantharidin inhibits the EZH2-mediated JAK2/STAT3 signaling pathway to inhibit the proliferation of non-small cell lung cancer. Toxicology and Applied Pharmacology 2026; 507 doi: 10.1016/j.taap.2026.117714
|
| 20 |
Qian Liu, Henglai Sun, Xinyu Li, Huagang Sheng, Liqiao Zhu. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. Molecules 2022; 27(22) doi: 10.3390/molecules27227740
|
| 21 |
Yifan Liu, Yushan Liang, Jing Yuhong, Peng Xin, Jia Li Han, Yongle Du, Xinru Yu, Runhe Zhu, Mingxun Zhang, Wen Chen, Yingjie Ma. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs. Drug Design, Development and Therapy 2024; doi: 10.2147/DDDT.S447496
|
| 22 |
Gorka Calvo-Martín, Daniel Plano, Nuria Martínez-Sáez, Carlos Aydillo, Esther Moreno, Socorro Espuelas, Carmen Sanmartín. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments. Pharmaceuticals 2022; 15(12) doi: 10.3390/ph15121465
|
| 23 |
Daixia Huo, Qiuxu An, Mingzhe Li, Xiaojie Lv. Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment. Microporous and Mesoporous Materials 2024; 369 doi: 10.1016/j.micromeso.2024.113013
|
| 24 |
Jing Wang, Gang Chen, Xue Yang, Wenwen Dou, Yuhang Mao, Yudie Zhang, Xiaotian Shi, Yehua Xia, Qiuyi You, Mei Liu. Inhibitory effects of norcantharidin on titanium particle-induced osteolysis, osteoclast activation and bone resorption via MAPK pathways. International Immunopharmacology 2024; 129 doi: 10.1016/j.intimp.2024.111655
|